Radiomics analysis in differentiating osteosarcoma and chondrosarcoma based on T2-weighted imaging and contrast-enhanced T1-weighted imaging
- PMID: 39496777
- PMCID: PMC11535035
- DOI: 10.1038/s41598-024-78245-1
Radiomics analysis in differentiating osteosarcoma and chondrosarcoma based on T2-weighted imaging and contrast-enhanced T1-weighted imaging
Abstract
This study was performed to investigate the diagnostic value of radiomics models constructed by fat suppressed T2-weighted imaging (T2WI-FS) and contrast-enhanced T1-weighted imaging (CET1) based on magnetic resonance imaging (MRI) for differentiation of osteosarcoma (OS) and chondrosarcoma (CS). In this retrospective cohort study, we included all inpatients with pathologically confirmed OS or CS from Second Xiangya Hospital of Central South University (Hunan, China) as of October 2020. Demographic and imaging variables were extracted from electronic medical records and compared between OS and CS group. Totals of 530 radiomics features were extracted from CET1 and T2WI-FS sequences based on MRI. The least absolute shrinkage and selection operator (LASSO) method was used for screening and dimensionality reduction of the radiomics model. Multivariate logistic regression analysis was performed to construct the radiomics model, and receiver operating characteristic curve (ROC) was generated to evaluate the diagnostic accuracy of the radiomics model. The training cohort and validation cohort included 87 and 29 patients, respectively. 8 CET1 features and 15 T2WI-FS features were screened based on the radiomics features. In the training group, the area under the receiver-operator characteristic curve (AUC) value for CET1 and T2WI-FS sequences in the radiomics model was 0.894 (95% CI 0.817-0.970) and 0.970 (95% CI 0.940-0.999), respectively. In the validation group, the AUC value for CET1 and T2WI-FS sequences in the radiomics model was 0.821 (95% CI 0.642-1.000) and 0.899 (95% CI 0.785-1.000), respectively. In this study, we developed a radiomics model based on T2WI-FS and CET1 sequences to differentiate between OS and CS. This model exhibits good performance and can help clinicians make decisions and optimize the use of healthcare resources.
Keywords: Chondrosarcoma; Differential diagnosis; Magnetic resonance imaging; Osteosarcoma; Radiomics.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Differentiation of Pelvic Osteosarcoma and Ewing Sarcoma Using Radiomic Analysis Based on T2-Weighted Images and Contrast-Enhanced T1-Weighted Images.Biomed Res Int. 2020 May 11;2020:9078603. doi: 10.1155/2020/9078603. eCollection 2020. Biomed Res Int. 2020. PMID: 32462033 Free PMC article.
-
Preoperative prediction of histopathological grading in patients with chondrosarcoma using MRI-based radiomics with semantic features.BMC Med Imaging. 2024 Jul 11;24(1):171. doi: 10.1186/s12880-024-01330-4. BMC Med Imaging. 2024. PMID: 38992609 Free PMC article.
-
Radiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.J Magn Reson Imaging. 2021 Oct;54(4):1314-1323. doi: 10.1002/jmri.27690. Epub 2021 May 5. J Magn Reson Imaging. 2021. PMID: 33949727 Clinical Trial.
-
[Radiomics models based on non-enhanced MRI can differentiate chondrosarcoma from enchondroma].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):483-490. doi: 10.12122/j.issn.1673-4254.2020.04.06. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32895139 Free PMC article. Chinese.
-
Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.Jpn J Radiol. 2024 Jul;42(7):709-719. doi: 10.1007/s11604-024-01544-0. Epub 2024 Feb 27. Jpn J Radiol. 2024. PMID: 38409300
Cited by
-
Multidimensional bioinformatics analysis of chondrosarcoma subtypes and TGF-β signaling networks using big data approaches.Discov Oncol. 2025 Jun 17;16(1):1136. doi: 10.1007/s12672-025-02931-3. Discov Oncol. 2025. PMID: 40526169 Free PMC article.
-
Building a Therapeutic Bridge Between Dogs and Humans: A Review of Potential Cross-Species Osteosarcoma Biomarkers.Int J Mol Sci. 2025 May 28;26(11):5152. doi: 10.3390/ijms26115152. Int J Mol Sci. 2025. PMID: 40507962 Free PMC article. Review.
-
Interpretable machine learning and radiomics in hip MRI diagnostics: comparing ONFH and OA predictions to experts.Front Immunol. 2025 Jan 29;16:1532248. doi: 10.3389/fimmu.2025.1532248. eCollection 2025. Front Immunol. 2025. PMID: 39944691 Free PMC article.
References
-
- Lin, Z., Xie, X., Lu, S. & Liu, T. Noncoding RNAs in osteosarcoma: implications for drug resistance. Cancer Lett.504, 91–103 (2021). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical